Blood Culture Test Market Size & Forecast Report, 2014 - 2025

Global Blood Culture Test Market is projected to reach USD 6.6 billion by 2025 owing to prevalence of blood infections and infectious diseases. Blood culture is a laboratory test wherein the patient’s blood is injected in bottles that contain culture media to determine the existence of infection-producing microorganisms like fungi or bacteria in the patient’s blood. It aims at confirming the existence of microorganisms in the blood, identifying the microbial etiology of the blood infection, helping to determine the infection source like endocarditis, and providing an organism for suspicion of testing and optimization of antimicrobial therapy. This test examines a sample of patient’s blood for yeast or bacteria that might be the root cause of infection. However, the growing demand for enhanced diagnostic techniques for the diagnosis of infectious diseases is expected to boost the blood culture tests market with a CAGR of 8.6%.

The blood infection, if left undetected, may lead to a severe and fatal condition called sepsis. The symptoms of bacteremia or initial bacterial infection are moderate or high fever, breathlessness, chills, muscular pain, palpitations, headache, tachycardia, and nausea. With the growth of infection, the indications also get serious; which may include dehydration, mottled skin, dizziness, confusion, drop in blood pressure, swelling, and organ failure.

Though blood samples are used for the detection of virus in blood, blood culture is essentially used to detect fungi or bacteria. Blood culture test is mostly done in combination with the other diagnostic tests like CBC (complete blood count) or the other chemical analysis. Different techniques like manual/conventional, automated and semi-automated methods could also be used to conduct blood culture test.

New product inventions, numerous regulatory approvals, rising sepsis conditions, growing number of infections in blood, increasing research & development of novel testing instruments and increasing number of adoptions for rapid diagnostic techniques are some factors that are bound to fuel blood culture test industry in the years to come. Additionally, the increasing elderly population and predominance of infectious disorders are the rest of key factors for the growth of the market.

However, costly automated instruments and shortage of skilled laboratory technicians are hampering the blood culture test market growth. Nevertheless, rising investments in Research & Development programs and increasing private and public healthcare expenditure are estimated to drive the market in the forecast period.

Blood culture test industry is categorized on the basis of method, product, application, end-user and geography. In terms of method, the market is divided into manual, conventional, and automated method. Based on product, the market is divided into instruments, consumables, and software & services.

Consumables could be further classified into culture media type, kits, accessories, and reagents. In terms of application, blood culture tests industry is divided into fungemia, bacteremia, and mycobacterial. On the basis of end-users, the market is divided into academic research laboratories, independent diagnostic laboratories, hospital laboratories, etc.

Geographically, blood culture test market is segmented as North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Europe and North America are predicted to dominate the market due to high spending power over healthcare. Asia Pacific is also expected to hold larger share in near future owing to the growing demand for blood culture tests from emerging nations.

The prominent blood culture test industry players profiled here are Abbott Laboratories, Bruker Corporation, Bayer Healthcare, bioMérieux SA, Becton Dickinson, Siemens AG, Merck, Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher) and Roche Diagnostics.

Market Segment:

Blood Culture Tests Product Outlook (Revenue, USD Million; 2014 - 2025)
    • Consumables
        • Blood culture media
            • Aerobic blood culture media
            • Anaerobic blood culture media
            • Fungi/yeast blood culture media
            • Others blood culture media
        • Assay, kits, and reagents
        • Blood culture accessories
    • Instruments
        • Laboratory equipment
            • Incubators
            • Colony counters
            • Microscopes
            • Gram stainers
        • Automated blood culture systems
    • Software & services

Blood Culture Tests Technique Outlook (Revenue, USD Million; 2014 - 2025)
    • Conventional blood culture technique
    • Automated blood culture technique

Blood Culture Tests Technology Outlook (Revenue, USD Million; 2014 - 2025)
    • Culture-based technology
    • Molecular technology
    • PCR
    • Microarray
    • PNA-FISH
    • Proteomic technology

Blood Culture Tests Application Outlook (Revenue, USD Million; 2014 - 2025)
    • Bacterial infections
    • Fungal infections
    • Mycobacterial infections

Blood Culture Tests End-use Outlook (Revenue, USD Million; 2014 - 2025)
    • Hospitals laboratories
    • Reference laboratories
    • Others

Blood Culture Tests Regional Outlook (Revenue, USD Million; 2014 - 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
    • MEA
        • South Africa